The Effect of Partner-Assisted Rebozo Application in the Intrapartum Period on Birth Fear, Pain and Satisfaction
Launched by ISTANBUL UNIVERSITY - CERRAHPASA · Mar 16, 2025
Trial Information
Current as of April 22, 2025
Not yet recruiting
Keywords
ClinConnect Summary
Childbirth is a challenging and life-changing experience for women that has emotional and physical effects. Every woman wants to remember her childbirth as a positive process, but the pain and suffering that accompanies this process can affect the perception of the pregnant woman. A long labor can increase complications for the baby and the mother. Despite all this, adapting to labor pain increases women's satisfaction with the labor process. For this, it is necessary to adopt methods that can reduce the duration and intensity of labor pain to a safe range and thus facilitate adaptation to ...
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Being literate,
- • Knowing Turkish,
- • Being over 18 years of age,
- • Being primiparous,
- • Having a single fetus and cephalic presentation,
- • Being at term (37-42 weeks),
- • Not having risk factors during pregnancy (Preeclampsia, premature rupture of membranes, oligohydramnios and polyhydramnios, gestational diabetes, placental anomalies, intrauterine growth retardation, intrauterine dead fetus, fetal distress, macrosomic babies, etc.),
- • Being in the active phase of the first stage of labor,
- • Those who agree to participate in the research,
- • The spouse also agrees to participate in the research.
- Exclusion Criteria:
- • Being multiparous,
- • Having multiple pregnancies,
- • Women with any chronic disease,
- • Women with a diagnosed psychiatric disease,
- • Pregnant women with spine and bone structure problems.
Trial Officials
DİLAN C Phd Candidate
Principal Investigator
Istanbul University - Cerrahpasa
About Istanbul University Cerrahpasa
Istanbul University - Cerrahpasa is a prestigious academic institution renowned for its commitment to advancing medical research and education. With a focus on innovative clinical trials, the university harnesses cutting-edge methodologies to address pressing health challenges. Its collaborative environment fosters interdisciplinary research, enabling the development of effective therapeutic strategies and enhancing patient care. The institution's dedication to ethical standards and patient safety underscores its reputation as a leader in clinical research within the region and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Zeyti̇nburnu, İ̇stanbul, Turkey
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported